Results 151 to 160 of about 34,402 (308)
Evaluating N95 respirator designs: A mixed-methods pilot and feasibility study. [PDF]
Sheikh F +5 more
europepmc +1 more source
Financial Distress and Its Determinants in Rheumatoid Arthritis
Objective To quantify the degree of financial distress and identify its determinants in adults with rheumatoid arthritis (RA) given the frequent prolonged use of expensive disease‐modifying therapies. Methods We identified adults enrolled in the FORWARD databank with either RA or noninflammatory musculoskeletal disease (NIMSKD) completing the ...
Amber Brown Keebler +5 more
wiley +1 more source
Real-Time Detection of Industrial Respirator Fit Using Embedded Breath Sensors and Machine Learning Algorithms. [PDF]
Aqueveque P +5 more
europepmc +1 more source
Objective Antinuclear antibodies (ANAs) are present at high titers in 2% of the general population, but their clinical significance in individuals without an autoimmune (AI) disease is not known. We tested the hypothesis that the presence of a high ANA titer in non‐AI conditions is associated with disease.
Matthew Chung +7 more
wiley +1 more source
Speech intelligibility and hearing acuity assessments of N95/P2 respirator with under-mask elastic band beard cover. [PDF]
Ng I +6 more
europepmc +1 more source
Artificial respiration and respirators [PDF]
openaire +2 more sources
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti +19 more
wiley +1 more source
Evaluation of the protective efficacy of a user seal check for N95 respirators through quantitative fit testing in an ambulance crew. [PDF]
Sawada H +4 more
europepmc +1 more source
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; NCT04179032) used three‐weight‐band ...
Hermine I. Brunner +14 more
wiley +1 more source

